Acute Leukemia and Myelodysplastic Syndromes Research Fund

Brian A. Jonas, MD, Ph.D., FACP is one of our lead clinician-scientist and principal investigators of many clinical trials testing various novel drug combinations' effectiveness in patients with acute myeloid leukemia, myelodysplastic syndrome (MDS), myeloproliferative neoplasms, and chronic myelomonocytic leukemia. Your support is critical in helping us discover new treatment approaches, combinations, and targeted therapies for both newly diagnosed and patients who have relapsed or are resistant to chemotherapy. Thank you for your belief in the UC Davis Comprehensive Cancer Center and your generosity. Through people like you, we can transform gifts to help heal patients.